Results 201 to 210 of about 87,925 (315)

Impact of national volume-based procurement policy on drugs treating chronic Myelogenous Leukemia. [PDF]

J Health Popul Nutr
Yang Z, Li Y, Liu S, Han X, Wu Y, Fan X, Li Y, Jiang B.   +7 more
europepmc   +1 more source

Inhibition of bcr-abl gene expression by small interfering RNA sensitizes for imatinib mesylate (STI571) [PDF]

, 2003
Lara Wohlbold, Heiko van der Kuip, Cornelius Miething, Hans‐Peter Vornlocher, Cornelius Knabbe, Justus Duyster, Walter E. Aulitzky   +6 more
openalex   +1 more source

Neoadjuvant Imatinib in Recurrent/Metastatic Gastrointestinal Stromal Tumors: A Systematic Review and Meta-analysis of Proportions. [PDF]

J Gastrointest Cancer
Stavrou N, Memos N, Filippatos C, Sergentanis TN, Zagouri F, Gavriatopoulou M, Ntanasis-Stathopoulos I.   +6 more
europepmc   +1 more source

Gynaecomastia in men with chronic myeloid leukaemia after imatinib [PDF]

, 2003
Carlo Gambacorti‐Passerini, Lucia Tornaghi, Francesco Cavagnini, Pellegrino Rossi, Francesca Pecori‐Giraldi, Luigi Mariani, Nadia Cambiaghi, Enrico Pogliani, Gianmarco Corneo, Lucio Gnessi   +9 more
openalex   +1 more source

Integrated Analysis of the Anoikis‐Related Signature Identifies Rac Family Small GTPase 3 as a Novel Tumor‐Promoter Gene in Hepatocellular Carcinoma

MedComm, Volume 6, Issue 4, April 2025.
A five‐gene risk model is constructed based on anoikis‐related genes by internal and external cross‐validation. The risk model serves as an independent prognostic factor for HCC. RAC3, a novel anoikis‐related oncogene in HCC, promotes cell proliferation and invasion, and inhibits apoptosis.
Dong Wu, Ze‐Kun Liu, Ying Sun, Chu‐Heng Gou, Run‐Ze Shang, Meng Lu, Ren‐Yu Zhang, Hao‐Lin Wei, Can Li, Ying Shi, Cong Zhang, Yu‐Tong Wang, Ding Wei, Zhi‐Nan Chen, Huijie Bian   +14 more
wiley   +1 more source

Disease-Drug-Drug Interaction of Imatinib in COVID-19 ARDS: A Pooled Population Pharmacokinetic Analysis. [PDF]

CPT Pharmacometrics Syst Pharmacol
Said MM, Schippers JR, Atmowihardjo L, Li Y, van der Plas MS, Bogaard HJ, Bos LDJ, Mathôt RAA, Aman J, Swart EL, Bartelink IH.   +10 more
europepmc   +1 more source

Erythema following imatinib mesylate [PDF]

, 2003
Edward Duncan, Kavita Raj, Ghulam Mufti
openalex   +1 more source

STAT3 Signaling Pathway in Health and Disease

MedComm, Volume 6, Issue 4, April 2025.
An image depicting the role of STAT3 in various human diseases ABSTRACT Signal transducer and activator of transcription 3 (STAT3) is a critical transcription factor involved in multiple physiological and pathological processes. While STAT3 plays an essential role in homeostasis, its persistent activation has been implicated in the pathogenesis of ...
Md Abdus Samad, Iftikhar Ahmad, Aakifah Hasan, Mohammad Hassan Alhashmi, Arusha Ayub, Fahad A. Al‐Abbasi, Ajoy Kumer, Shams Tabrez   +7 more
wiley   +1 more source

Tenascin-C Facilitates Microglial Polarization via TLR4/MyD88/NF-κB Pathway Following Subarachnoid Hemorrhage. [PDF]

J Inflamm Res
Hu ZQ, Ma R, Sun JQ, Peng M, Yuan J, Lai N, Liu J, Xia D.   +7 more
europepmc   +1 more source

Analysis of the impact of imatinib mesylate therapy on the prognosis of patients with Philadelphia chromosome–positive chronic myelogenous leukemia treated with interferon‐α regimens for early chronic phase [PDF]

, 2003
Hagop M. Kantarjian, Susan O’Brien, Jorge E. Cortés, Jianqin Shan, Francis J. Giles, Guillermo Garcia‐Manero, Srđan Verstovšek, Stefan Faderl, Mary Beth Rios, Moshe Talpaz   +9 more
openalex   +1 more source